Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank67
3Y CAGR-65.1%
5Y CAGR-46.2%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-65.1%/yr
Annual compound
5Y CAGR
-46.2%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 0.31% |
| 2024 | -13.38% |
| 2023 | -47.41% |
| 2022 | 7.35% |
| 2021 | -4.59% |
| 2020 | 6.92% |
| 2019 | -206.60% |
| 2018 | 0.00% |
| 2013 | 77.65% |
| 2012 | 0.00% |